Cargando…
Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281643/ https://www.ncbi.nlm.nih.gov/pubmed/37352879 http://dx.doi.org/10.1016/S1473-3099(23)00357-2 |
| _version_ | 1785061043383304192 |
|---|---|
| author | Solera, Javier T Ierullo, Matthew Arbol, Berta G Mavandadnejad, Faranak Kurtesi, Alexandra Qi, Freda Hu, Queenie Gingras, Anne-Claude Ferreira, Victor H Humar, Atul Kumar, Deepali |
| author_facet | Solera, Javier T Ierullo, Matthew Arbol, Berta G Mavandadnejad, Faranak Kurtesi, Alexandra Qi, Freda Hu, Queenie Gingras, Anne-Claude Ferreira, Victor H Humar, Atul Kumar, Deepali |
| author_sort | Solera, Javier T |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10281643 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102816432023-06-21 Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients Solera, Javier T Ierullo, Matthew Arbol, Berta G Mavandadnejad, Faranak Kurtesi, Alexandra Qi, Freda Hu, Queenie Gingras, Anne-Claude Ferreira, Victor H Humar, Atul Kumar, Deepali Lancet Infect Dis Correspondence Elsevier Ltd. 2023-06-20 /pmc/articles/PMC10281643/ /pubmed/37352879 http://dx.doi.org/10.1016/S1473-3099(23)00357-2 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Solera, Javier T Ierullo, Matthew Arbol, Berta G Mavandadnejad, Faranak Kurtesi, Alexandra Qi, Freda Hu, Queenie Gingras, Anne-Claude Ferreira, Victor H Humar, Atul Kumar, Deepali Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients |
| title | Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients |
| title_full | Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients |
| title_fullStr | Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients |
| title_full_unstemmed | Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients |
| title_short | Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients |
| title_sort | bivalent covid-19 mrna vaccine against omicron subvariants in immunocompromised patients |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281643/ https://www.ncbi.nlm.nih.gov/pubmed/37352879 http://dx.doi.org/10.1016/S1473-3099(23)00357-2 |
| work_keys_str_mv | AT solerajaviert bivalentcovid19mrnavaccineagainstomicronsubvariantsinimmunocompromisedpatients AT ierullomatthew bivalentcovid19mrnavaccineagainstomicronsubvariantsinimmunocompromisedpatients AT arbolbertag bivalentcovid19mrnavaccineagainstomicronsubvariantsinimmunocompromisedpatients AT mavandadnejadfaranak bivalentcovid19mrnavaccineagainstomicronsubvariantsinimmunocompromisedpatients AT kurtesialexandra bivalentcovid19mrnavaccineagainstomicronsubvariantsinimmunocompromisedpatients AT qifreda bivalentcovid19mrnavaccineagainstomicronsubvariantsinimmunocompromisedpatients AT huqueenie bivalentcovid19mrnavaccineagainstomicronsubvariantsinimmunocompromisedpatients AT gingrasanneclaude bivalentcovid19mrnavaccineagainstomicronsubvariantsinimmunocompromisedpatients AT ferreiravictorh bivalentcovid19mrnavaccineagainstomicronsubvariantsinimmunocompromisedpatients AT humaratul bivalentcovid19mrnavaccineagainstomicronsubvariantsinimmunocompromisedpatients AT kumardeepali bivalentcovid19mrnavaccineagainstomicronsubvariantsinimmunocompromisedpatients |